GENEREX BIOTECHNOLOGY CORP — Form D

GENEREX BIOTECHNOLOGY CORP of TORONTO ONTARIO CANADA, A1, a company, filed a Form D exempt-offering notice with the SEC on 2020-09-11. $2.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
James AndersonDirectorSouthfield, MI
Craig EagleDirectorGrasonville, MD
Brian McGeeDirectorBOCA RATON, FL
Joseph MoscatoDirectorMiramar, FL
Mark PriolettiDirectorMiramar, FL
Andrew RoDirectorMiramar, FL
Lawrence SalvoDirectorMiramar, FL
Mark CorraoExecutive OfficerMiramar, FL
Anthony CrisciExecutive OfficerMiramar, FL
Joseph MoscatoExecutive OfficerMiramar, FL
Richard PurcellExecutive OfficerMiramar, FL
Andrew RoExecutive OfficerMiramar, FL
Jason TerrellExecutive OfficerMiramar, FL
Terry ThompsonExecutive OfficerLincoln, NE
Nola E MastersonDirectorBloomfield Hills, MI
Mark A FletcherDirectorMinneapolis, MN
Mark A FletcherExecutive OfficerMinneapolis, MN
Eric E von Hofe, Ph.D.DirectorTORONTO, A6
James H Anderson, Jr., M.D.DirectorTORONTO, A6
Brian T McGeeDirectorTORONTO, A6
John P BarrattDirectorTORONTO, A6
David H Brusegard, Ph.D.Executive OfficerTORONTO, A6
Stephen H FellowsExecutive OfficerTORONTO, A6
Brian T. McGeeDirectorTORONTO, A6
James H. Anderson, Jr., M.D.DirectorTORONTO, A6

Other filings by this issuer (2)

FiledFormOfferingSold
2012-09-05D$750K$750K
2012-02-07D$2.0M$2.0M

More